Haiting Wang1, Xiangyu Teng2, Georges Abboud2, Wei Li2, Shuang Ye1, Laurence Morel3. 1. Department of Rheumatology, RenJi Hospital South Campus, School of Medicine, Shanghai Jiaotong University, Shanghai, China. 2. Department of Pathology, Immunology and Laboratory Medicine, University of Florida, JHMHC 275, Box 100275, Gainesville, FL, 32610-0275, USA. 3. Department of Pathology, Immunology and Laboratory Medicine, University of Florida, JHMHC 275, Box 100275, Gainesville, FL, 32610-0275, USA. morel@ufl.edu.
Abstract
BACKGROUND: Systemic lupus erythematosus is an autoimmune disease characterized by an overproduction of autoantibodies resulting from dysregulation in multiple immune cell types. D-mannose is a C- 2 epimer of glucose that exhibits immunoregulatory effects in models of autoimmune diseases, such as type 1 diabetes, induced rheumatoid arthritis, and airway inflammation. This study was conducted to evaluate the efficacy of D-mannose treatment in mouse models of lupus. RESULTS: Firstly, the effect of D-Mannose was evaluated by flow cytometry on the in vitro activation of non-autoimmune C57BL/6 (B6) bone marrow-derived dendritic cells (BMDCs) and their ability to induce antigen-specific CD4+ T cell proliferation and activation. D-mannose inhibited the maturation of BMDCs and their induction of antigen-specific T cell proliferation and activation. In vivo, D-mannose increased the frequency of Foxp3+ regulatory T cells in unmanipulated B6 mice. To assess the effect of D-mannose in mouse models of lupus, we used the graft-versus-host disease (cGVHD) induced model and the B6.lpr spontaneous model. In the cGVHD model, D-mannose treatment decreased autoantibody production, with a concomitant reduction of the frequency of effector memory and follicular helper T cells as well as germinal center B cells and plasma cells. These results were partially validated in the B6.lpr model of spontaneous lupus. CONCLUSION: Overall, our results suggest that D-mannose ameliorates autoimmune activation in models of lupus, at least partially due to its expansion of Treg cells, the induction of immature conventional dendritic cells and the downregulation of effector T cells activation. D-Mannose showed however a weaker immunomodulatory effect in lupus than in other autoimmune diseases.
BACKGROUND: Systemic lupus erythematosus is an autoimmune disease characterized by an overproduction of autoantibodies resulting from dysregulation in multiple immune cell types. D-mannose is a C- 2 epimer of glucose that exhibits immunoregulatory effects in models of autoimmune diseases, such as type 1 diabetes, induced rheumatoid arthritis, and airway inflammation. This study was conducted to evaluate the efficacy of D-mannose treatment in mouse models of lupus. RESULTS: Firstly, the effect of D-Mannose was evaluated by flow cytometry on the in vitro activation of non-autoimmune C57BL/6 (B6) bone marrow-derived dendritic cells (BMDCs) and their ability to induce antigen-specific CD4+ T cell proliferation and activation. D-mannose inhibited the maturation of BMDCs and their induction of antigen-specific T cell proliferation and activation. In vivo, D-mannose increased the frequency of Foxp3+ regulatory T cells in unmanipulated B6 mice. To assess the effect of D-mannose in mouse models of lupus, we used the graft-versus-host disease (cGVHD) induced model and the B6.lpr spontaneous model. In the cGVHD model, D-mannose treatment decreased autoantibody production, with a concomitant reduction of the frequency of effector memory and follicular helper T cells as well as germinal center B cells and plasma cells. These results were partially validated in the B6.lpr model of spontaneous lupus. CONCLUSION: Overall, our results suggest that D-mannose ameliorates autoimmune activation in models of lupus, at least partially due to its expansion of Treg cells, the induction of immature conventional dendritic cells and the downregulation of effector T cells activation. D-Mannose showed however a weaker immunomodulatory effect in lupus than in other autoimmune diseases.
Entities:
Keywords:
D-mannose; Dendritic cells; Systemic lupus erythematosus; T cells
Authors: Sun-Sang J Sung; Yan Ge; Chao Dai; Hongyang Wang; Shu Man Fu; Rahul Sharma; Young S Hahn; Jing Yu; Thu H Le; Mark D Okusa; Warren K Bolton; Jessica R Lawler Journal: J Immunol Date: 2017-02-20 Impact factor: 5.422
Authors: Wen-Hai Shao; Ana M Gamero; Yuxuan Zhen; Monica J Lobue; Stephen O Priest; Hazem J Albandar; Philip L Cohen Journal: J Immunol Date: 2015-09-21 Impact factor: 5.422
Authors: Kimberley Chiu; Fan Zhang; Siobhan Sutcliffe; Indira U Mysorekar; Jerry L Lowder Journal: Female Pelvic Med Reconstr Surg Date: 2022-03-01 Impact factor: 2.091
Authors: Mingyang Li; Haiyan Cheng; Dan Tian; Lu Yang; Xiaonan Du; Yuhualei Pan; Dong Zhang; Xueling Mei Journal: Front Immunol Date: 2022-02-28 Impact factor: 7.561